News & Events
Your location:
Home
/
/
/
HOPE pharmaceutical won "top 20 Chinese pharmaceutical r&d companies" again

HOPE pharmaceutical won "top 20 Chinese pharmaceutical r&d companies" again

(Summary description)Sponsored by the all_china federation of medicine chamber of commerce of the "2018 most influential list Chinese medicine industry conference and the 11th China (jinan) medicine industry development peak BBS", held on June 3, 5, 2019, the site unveiled 2018 year China top 50 top pharmaceutical industry, China's pharmaceutical industry growth, such as Chinese medicine research and development company 20 13 blockbuster awards.

HOPE pharmaceutical won "top 20 Chinese pharmaceutical r&d companies" again

(Summary description)Sponsored by the all_china federation of medicine chamber of commerce of the "2018 most influential list Chinese medicine industry conference and the 11th China (jinan) medicine industry development peak BBS", held on June 3, 5, 2019, the site unveiled 2018 year China top 50 top pharmaceutical industry, China's pharmaceutical industry growth, such as Chinese medicine research and development company 20 13 blockbuster awards.

Information
 
Sponsored by the all_china federation of medicine chamber of commerce of the "2018 most influential list Chinese medicine industry conference and the 11th China (jinan) medicine industry development peak BBS", held on June 3, 5, 2019, the site unveiled 2018 year China top 50 top pharmaceutical industry, China's pharmaceutical industry growth, such as Chinese medicine research and development company 20 13 blockbuster awards.
As a comprehensive drug research and development institution with business covering the research and development of API and pharmaceutical preparations and clinical trial services, Beijing haibu pharmaceutical technology co., ltd. has been awarded the title of "top 20 Chinese pharmaceutical research and development companies" for two consecutive years.
HOPE pharmaceutical was selected as "top 20 pharmaceutical r&d companies in China" by the joint efforts of all colleagues and the recognition and support of partners. The company will further strengthen the improvement of r&d skills and application of innovative technologies, and serve customers with more rigorous r&d attitude and more efficient technology transformation capacity.
【Introduction to HOPE medicine】
Founded in April 2005 (stock code: 836438), Beijing haibu pharmaceutical technology co., ltd. is a high_tech enterprise of the whole industrial chain mainly engaged in the research and development, production and sales of chemical drugs. The company's main business covers pharmaceutical and clinical CRO services, research and development, associated registration and customized production of high_end bulk drugs and pharmaceutical intermediates, as well as the research and development of chemical pharmaceutical preparations and MAH business. Research and development products are involved in anti_tumor, anti_depression, cardiovascular and cerebrovascular, digestive system, respiratory system and other fields.
In China, it has obtained more than 60 approval documents for clinical trials, more than 10 approval documents for new drugs and drug registration, and more than 10 series of high_end API and intermediate products have been commercialized and marketed and sold globally.
The company is committed to the optimization and innovation of chemical medicine synthesis process, and has achieved a series of excellent achievements in the application of innovative technologies such as efficient asymmetric catalysis, enzyme catalysis and continuous flow reaction technology, challenge crystal and process technology patents, small molecule structure transformation and so on.
【cooperation information】
Business cooperation: Chen zhutuo tel: 18010182349 email: chenzhutuo@hopelife.cn
API cooperation: yufuqiang tel: 15010704183 email: yufuqiang@hopelife.cn
Keyword:

Scan the QR code to read on your phone

  

Beijing Hope Pharmaceutical Co., Ltd.   京ICP备17065299号

这是描述信息